The pharmaceutical industry has been in the firing line of competition law regulators ever since the European Commission's 2008 pharmaceutical sector inquiry...
The UK Government and NHS said in 2014 that it wanted to expedite and facilitate access for NHS patients to innovative medicines, medical technologies, diagnostics and digital products for which there is an urgent need.
During the Brexit process, the UK government and EU negotiators are setting out their positions in a series of papers. The government has put forward two Position Papers recently...
The UK Government has published a series of position papers on Brexit. In one, it has sought to reassure business and individuals that it will be 'business as usual' in terms of enforcing their legal rights where there is a cross-border element.
The Home Secretary, Amber Rudd, has commissioned the Migration Advisory Committee (MAC) to carry out a detailed analysis and prepare a report on migration from the European Economic Area (EEA).
The Pharmaceutical Services Negotiating Committee (PSNC) announced at this year's Pharmacy Show in Birmingham that it will be taking steps to further encourage the interaction between GPs and pharmacists.
Big pharma giant GlaxoSmithKline (GSK) has been reported as making significant progress with the use of artificial intelligence (AI) technology and supercomputers for the discovery of new drugs using old trial data.
The EU Withdrawal Bill (previously known as The Great Repeal Bill) has been introduced to Parliament and has been making its way through the legislative approval process.
The UK Government has published a series of position papers on Brexit. In one, it has sought to give comfort to citizens, businesses and institutions on the exchange and protection of personal data.
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its annual report and accounts, highlighting some of its key achievements.
